ArticleSkin health and disease2026

Efficacy and safety of spesolimab in resistant pyoderma gangrenosum: a case report and brief review of the literature.

Kmar Turki et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.